EXEL Sue Gail Eckhardt sells $823K worth of shares
Jun 05, 2025, 4:33 AM
0.00%
What does EXEL do
Exelixis, an oncology company based in Alameda, California, focuses on developing treatments for difficult-to-treat cancers, with four marketed products including cabozantinib for various cancers. Founded in 2000, it employs 1,310 people.
Sue Gail Eckhardt sold 18,838 shares of EXEL on 2 June at $43.67 per share, worth a total of $823K. They now own 21,384 EXEL shares, or a 47% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
